Herbas VPB

Print
EN | LT
LT - Triazolo junginiai, kurie moduliuoja HSP90 aktyvumą
EN - TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 249/12 (2006.01)
C07D 401/04 (2006.01)
C07D 405/04 (2006.01)
C07D 403/04 (2006.01)
A61K 31/4196 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 1817295
(13) Kind of document T
(96) European patent application number 05851788.9
Date of filing the European patent application 2005-11-17
(97) Date of publication of the European application 2007-08-15
(45) Date of publication and mention of the grant of the patent 2012-11-07
(46) Date of publication of the claims translation 2013-03-25
PCT application
(86) Number PCT/US2005/041779
Date 2005-11-17
PCT application publication
(87) Number WO 2006/055760
Date 2006-05-26
Priority applications
(30) Number Date Country code
628979 P 2004-11-18 US
709358 P 2005-08-18 US
725044 P 2005-10-06 US
Inventors
(72)
YING, Weiwen, US
JAMES, David, US
ZHANG, Shijie, US
PRZEWLOKA, Teresa, US
CHAE, Junghyun, KR
CHIMMANAMADA, Dinesh, U., US
LEE, Chi-Wan, US
KOSTIK, Elena, US
NG, Howard, P., US
FOLEY, Kevin, US
DU, Zhenjian, US
BARSOUM, James, US
Grantee
(73) Synta Pharmaceuticals Corp., 45 Hartwell Avenue, Lexington, MA 02421, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Triazolo junginiai, kurie moduliuoja HSP90 aktyvumą
  TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
Last renewal fee
Payment date Validity (years) Amount
2016-11-18 12 433.50 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2017-11-17